Antiviral treatment and response are associated with lower risk of dementia among hepatitis C virus-infected patients
- Resource Type
- Article
- Authors
- Tao, Meng-Hua; Gordon, Stuart; Wu, Trueman; Trudeau, Sheri; Rupp, Loralee B.; Gonzalez, Humberto C.; Daida, Yihe G.; Schmidt, Mark A.; Lu, Mei
- Source
- The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry; 20230101, Issue: Preprints
- Subject
- Language
- ISSN
- 10647481; 15457214
•What is the primary question addressed by this study?Are hepatitis C antiviral treatments associated with risk of dementia among patients with hepatitis C virus?•What is the main finding of this study?This study found that hepatitis C-infected patients who achieved sustained virological response had significantly decreased risk of dementia compared to untreated patients the risk of dementia.•What is the meaning of the finding?These findings suggest that timely accessing antiviral therapy in chronic hepatitis C-infected patients is important to reduce dementia burden.